Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pertussis toxin mutants, Bordetella strains capable of producing such mutants and their use in the development of antipertussis vaccines

Pertussis toxin mutants, Bordetella strains capable of producing such mutants and their use in the development of antipertussis vaccines

US Patent 7666436 · Granted Feb 23, 2010

Estimated economic value: $9,421,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Vaccines for Neisseria gonorrhoeae2024
Immunogenic compositions comprising OMVs, an acellular pertussis antigen, a teta2024
Vaccines for Neisseria gonorrhoeae2024
Adjuvanted vaccines with non-virion antigens prepared from influenza viruses gro2023
Vaccination of immunocompromised subjects2022
Adjuvanted vaccines with non-virion antigens prepared from influenza viruses gro2020
Vaccination of immunocompromised subjects2020
Adjuvanted combinations of meningococcal factor H binding proteins2020
Combinations of meningococcal factor H binding proteins2019
Vaccines for serogroup X meningococcus2019
Immunogenic bacterial vesicles with outer membrane proteins2019
Multiple variants of meningococcal protein NMB18702019